| Affiliation: | 1. Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA;2. Lymphocyte Development Group, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK;1. Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK;1. Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC) Campus-Vienna-Biocenter 1, 1030 Vienna, Austria;2. Insitute for Biophysics, Johannes Kepler University Linz, Life Science Center, Gruberstrasse 40, 4020 Linz, Austria;3. Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, A-1030 Vienna, Austria;1. Epigenetics and Genome Stability Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK;2. Bioinformatics Group, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UK;3. Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK;1. Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA;2. Department of Chemistry, Stanford University, Stanford, CA, USA;3. Biophysics Program, Stanford University, Stanford, CA, USA;4. Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA;5. Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA;6. Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA;1. Stowers Institute for Medical Research, Kansas City, MO 64110, United States;2. Department of Biochemistry and Molecular Biology, University of Kansas School of Medicine, Kansas City, KS 66160, United States;1. MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK;2. Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK |
